Back

Prognostic value of admission left ventricular outflow tract velocity time integral in hospitalized heart failure patients with preserved ejection fraction: a report from the JASPER registry

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Heart failure: prognosis, outcome Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Kazunori Omote

Hokkaido Cardiovascular Hospital, Sapporo (Japan)

9 More presentations in this session

Presentation thumbnail
Diffuse coronary artery disease and effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure
Doctor C. Byrne (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Predicting cardiac recovery before durable left ventricular assist device implantation in advanced heart failure patients
Doctor S. Drakos (Salt Lake City, US)
Abstract Slides
Presentation thumbnail
Early benefits of empagliflozin in patients with type 2 diabetes with heart failure are not offset by increased adverse events: results from the EMPA-REG OUTCOME trial
Doctor P. Pellicori (Glasgow, GB)
Abstract
Presentation thumbnail
Incidence and prognostic impact of new-onset left bundle branch block in patients with heart failure and reduced ejection fraction
Professor L. Kober (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Improved attitudes of non-cardiologists towards decreased left ventricular ejection fraction after marking "warning" on echocardiography report
Miss Q. Chen (Chengdu, CN)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Heart failure: prognosis, outcome

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources